Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Back
Association details:
Biomarker:
No biomarker
Cancer:
Ovarian Cancer
Drug:
carboplatin
(
Tubulin polymerization promoter
) +
Paclical (micellar paclitaxel)
(
Bcl2 inhibitor
,
Tubulin inhibitor
)
Direction:
Sensitive
Evidence:
Evidence Level:
Sensitive: A1 - Approval
Source:
European Medicines Agency
Published date:
11/20/2018
Excerpt:
Apealea in combination with carboplatin is indicated for the treatment of adult patients with first relapse of platinum‑sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer.
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login